Close Menu

This story has been updated to include comment from Illumina.

NEW YORK – A judge in the US District Court for the Northern District of California has granted in part and denied in part Illumina's motion to dismiss claims of patent infringement that were filed against it in October 2019 by BGI and its affiliates.

The court has also issued an order striking several of BGI's affirmative defenses in the patent infringement suit Illumina filed against the company last June.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

A German shepherd called Nala has had her genome sequenced.

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.